89bio, Inc. (ETNB)

89bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	36.53	28.97	21.45	19.41	13.16	5.29
Research & Development	267.33	122.23	80.8	70.33	36.2	21.35
Total Operating Expenses	303.86	151.2	102.25	89.74	49.36	26.64
Operating Income	-303.86	-151.2	-102.25	-89.74	-49.36	-26.64
Interest Expense	-4.97	-4.79	-1.92	-0.67	-	-
Other Non-Operating Income (Expense)	24.16	17.68	2.16	0.15	0.2	30.56
Total Non-Operating Income (Expense)	19.2	12.88	0.24	-0.53	0.2	30.56
Pretax Income	-284.66	-138.32	-102.01	-90.27	-49.56	-57.2
Provision for Income Taxes	4.3	3.87	0.02	-0.15	-	-
Net Income	-288.96	-142.19	-102.03	-90.12	-49.5	-57.42
Net Income to Common	-288.96	-142.19	-102.03	-90.12	-49.5	-57.42
Shares Outstanding (Basic)	96	71	35	20	16	2
Shares Outstanding (Diluted)	96	71	35	20	16	2
Shares Change (YoY)	50.60%	104.48%	73.18%	24.93%	586.28%	428.25%
EPS (Basic)	-2.91	-2.00	-2.93	-4.48	-3.08	-24.49
EPS (Diluted)	-2.91	-2.00	-2.93	-4.48	-3.08	-24.49
Free Cash Flow	-	-129.19	-81.1	-76.84	-46.37	-25.6
Free Cash Flow Per Share	-	-1.82	-2.33	-3.82	-2.88	-10.92
EBITDA	-303.86	-151.15	-102.18	-89.66	-49.3	-26.62
EBIT	-303.86	-151.2	-102.25	-89.74	-49.36	-26.64
Effective Tax Rate	-1.51%	-2.80%	-0.02%	0.16%	0.00%	0.00%

Updated May 2, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q